US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Osmond Resources Ltd (OSM) 銘柄情報

Osmond Resources Ltd (OSM)

0.46

-0.035

(-7.07%)

終了 6月7日 3:00PM

Osmond Resources Ltd (OSM) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.46

( -7.07% )

買値

0.45

売値

0.48

出来高

55,089

0.46 日の範囲 0.485

0.40 52 週間の範囲 1.12

時価総額

前日終値

0.495

始値

0.485

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 93,232

発行済株式数

138,027,916

配当利回り

PER

-4.58

1 株当たり利益 (EPS)

-0.12

歳入

12.86k

純利益

-12.73M

Osmond Resources Limited operates as an early-stage mineral exploration and development company in Australia. The company primarily explores for gold, uranium, nickel, copper, platinum group, and rare earth elements. Its flagship project is Orion EU Critical Minerals Project, covering an area of 228... Osmond Resources Limited operates as an early-stage mineral exploration and development company in Australia. The company primarily explores for gold, uranium, nickel, copper, platinum group, and rare earth elements. Its flagship project is Orion EU Critical Minerals Project, covering an area of 228 square kilometers, located in Southern Spain. Osmond Resources Limited was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

osmondresources.com.au

本社

Melbourne, Australia

設立

2026

Osmond Resources Ltd is listed in the Materials sector of the オーストラリア証券取引所 with ticker OSM. The last closing price for Osmond Resources was AUD0.50. Over the last year, Osmond Resources shares have traded in a share price range of AUD 0.40 to AUD 1.12.

Osmond Resources currently has 138,027,916 shares in issue. The market capitalisation of Osmond Resources is AUD63.49 million. Osmond Resources has a price to earnings ratio (PE ratio) of -4.58.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.04	9.52380952381	0.42	0.555	0.42	100476	0.52296888	DE
4	-0.09	-16.3636363636	0.55	0.555	0.4	77946	0.48673366	DE
12	-0.07	-13.2075471698	0.53	0.68	0.4	95686	0.53031729	DE
26	-0.455	-49.7267759563	0.915	0.915	0.4	131484	0.59117324	DE
52	-0.04	-8	0.5	1.12	0.4	168020	0.7720775	DE
156	0.29	170.588235294	0.17	1.12	0.062	163168	0.5031295	DE
260	0.24	109.090909091	0.22	1.12	0.062	146941	0.4673793	DE

OSM - Frequently Asked Questions (FAQ)

What is the current Osmond Resources Ltd share price?

The current share price of Osmond Resources Ltd is AUD 0.46

How many Osmond Resources Ltd shares are in issue?

Osmond Resources Ltd has 138,027,916 shares in issue

What is the market cap of Osmond Resources Ltd?

The market capitalisation of Osmond Resources Ltd is AUD 63.49M

What is the 1 year trading range for Osmond Resources Ltd share price?

Osmond Resources Ltd has traded in the range of AUD 0.40 to AUD 1.12 during the past year

What is the PE ratio of Osmond Resources Ltd?

The price to earnings ratio of Osmond Resources Ltd is -4.58

What is the cash to sales ratio of Osmond Resources Ltd?

The cash to sales ratio of Osmond Resources Ltd is 5.9k

What is the registered address of Osmond Resources Ltd?

The registered address for Osmond Resources Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Osmond Resources Ltd website address?

The website address for Osmond Resources Ltd is osmondresources.com.au

Which industry sector does Osmond Resources Ltd operate in?

Osmond Resources Ltd operates in the Mining sector

DTGoody

DTGoody 3分前

Yes, I was playing that Damn VMH* which appears I jinxed as usual! That's another one pissing me off! LOL I could have bought a ton more shares here if I reacted better to the news and switched things around if you know what I mean. Instead, I had my thumb up my Rear while this Gem keeps running! LO

Myth

Hand Of Fate · The Rolling Stones

https://www.youtube.com/watch?v=3RGhtDjup38

badshah

badshah 4分前

School teacher...but you have no shares...so why the interest????

dewophile

dewophile 5分前

I’ll check it out thanks. A key point is that ketones can rise even when glucose levels are within range. I’m not sure the commercial opportunity but it sounds not only limited to type 1 diabetics. It also seems like dexcom has greater market share in intensive insulin users and this is the populati

Myth

The Rolling Stones - One Hit (To The Body)

https://www.youtube.com/watch?v=dx2WRQLSIew

1plus1

A Once in a lifetime opportunity, BIEI will make history next week in Mexico, World Cup and we sponsor the product … possible dream come true

jerkviewer

jerkviewer 5分前

i would love to know what he thinks our chances are

jerkviewer

jerkviewer 6分前

it might not be such a longshot....it definitely would change the valuation....nas will hopefully expand on that topic on the cc

eur06

ok it’ll be fine to wait, no rush from me.
GLND

1plus1

1plus1 10分前

LET'S HOPE THEY WILL USE THE PRODUCTS IN FIFFA CUP NEXT WEEK >> THIS WILL BE SWEEEEEEEEEEET AND OVER .10+ CENTS

FOFreddie

FOFreddie 11分前

Ackman is a billionaire friend who would probably this resolved ASAP. John Paulson is a billionaire friend who also probably wants this resolved ASAP. They really need to come out with a Housing Plan ASAP as you mentioned. Also - why would Trump want to leave any money on the table for the nex

DTGoody

DTGoody 11分前

Why would Cohen be involved with ENCC??? I'm sorry, but I don't see the connection between him and ENCC.

DTGoody

DTGoody 13分前

We will be on entirely differently exchange then!

flipper44

flipper44 13分前

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication, morphing plans, spending, and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad 13分前

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it.

The o t c is the world's largest casino, where the only game is liars poker.

Riding many, many,

Myth

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence 15分前

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts 15分前

tisdal

tisdal 16分前

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie 17分前

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence 20分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader 20分前

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence 21分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 21分前

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

Osmond Resources

JPM Betabuilders Us Smal...

Ci Global Equity Pool Se...

SavvyLong Geared Natural...

Fidelity EUR HY Corp Bon...

Maximus Resources

Larvotto Resources

Flt Rte Nts 23/02/27

Sap Peer Group PR USD

FROF37 - 01/2037

Henderson European

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。